Word

XAVEJMA

Status

Pending

Status Code

730

Status Date

Thursday, December 21, 2023

Serial Number

97636870

Mark Type

4000

Filing Date

Tuesday, October 18, 2022

Published for Opposition

Tuesday, May 2, 2023

Trademark Owner History

TEVA PHARMACEUTICALS USA, Inc. - Owner At Publication

Classifications

5 Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders (skin), musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders; pharmaceutical preparations for use in the treatment of oncological and metabolic diseases and disorders; pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations

Trademark Events

Dec 23, 2023

Notice Of Approval Of Extension Request E-Mailed

Dec 21, 2023

Sou Extension 1 Granted

Dec 21, 2023

Sou Extension 1 Filed

Dec 21, 2023

Sou Teas Extension Received

Jun 27, 2023

Noa E-Mailed - Sou Required From Applicant

May 2, 2023

Official Gazette Publication Confirmation E-Mailed

May 2, 2023

Published For Opposition

Apr 12, 2023

Notification Of Notice Of Publication E-Mailed

Mar 28, 2023

Approved For Pub - Principal Register

Mar 28, 2023

Assigned To Examiner

Nov 2, 2022

New Application Office Supplied Data Entered

Oct 21, 2022

New Application Entered